Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online January 9, 2008
Diabetes Care 31:753-757, 2008
DOI: 10.2337/dc07-1750
© 2008 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dc07-1750v1
31/4/753    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shields, B. M.
Right arrow Articles by Hattersley, A. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shields, B. M.
Right arrow Articles by Hattersley, A. T.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Pathophysiology/Complications
Original Research

Mutations in the Glucokinase Gene of the Fetus Result in Reduced Placental Weight

Beverley M. Shields, PHD1, Gill Spyer, MD, MRCP1, Annabelle S. Slingerland, MD, MPH1, Bridget A. Knight, PHD1,2, Sian Ellard, PHD, MRCPATH2, Penelope M. Clark, PHD, FRCPATH3, Sylvie Hauguel-de Mouzon, PHD4 and Andrew T. Hattersley, DM, FRCP1

1 Peninsula Medical School, Exeter, U.K.
2 Royal Devon and Exeter Hospital, Exeter, U.K.
3 Regional Endocrine Laboratory, University Hospital Birmingham NHS Trust, Birmingham, U.K.
4 Case Western Reserve University, Cleveland, Ohio

Address correspondence and reprint requests to Professor Andrew T. Hattersley, Diabetes Research, Peninsula Medical School, Barrack Road, Exeter, EX2 5DW, U.K. E-mail: andrew.hattersley{at}pms.ac.uk

OBJECTIVE—In human pregnancy, placental weight is strongly associated with birth weight. It is uncertain whether there is regulation of the placenta by the fetus or vice versa. We aimed to test the hypothesis that placental growth is mediated, either directly or indirectly, by fetal insulin.

RESEARCH DESIGN AND METHODS—Birth weight and placental weight were measured in 43 offspring of 21 parents with mutations in the glucokinase (GCK) gene (25 had inherited the mutation and 18 had not), which results in reduced fetal insulin secretion. Birth weight, placental weight, umbilical cord insulin, and maternal glucose and insulin concentrations were measured in 573 nondiabetic, healthy, term pregnancies.

RESULTSGCK mutation carriers were lighter and also had smaller placentas (610 vs. 720 g, P = 0.042). This difference was also seen in 17 discordant sibling pairs (600 vs. 720 g, P = 0.003). GCK mRNA was not detected in the placenta by RT-PCR. In the normal pregnancies, placental weight was strongly correlated with birth weight (r = 0.61, P < 0.001). Cord insulin concentrations were directly related to placental weight (r = 0.28) and birth weight (r = 0.36) (P < 0.001 for both).

CONCLUSIONS—These results suggest that insulin, directly or indirectly, plays a role in placental growth, especially as a mutation in the GCK gene, which is known to only alter fetal insulin secretion, results in altered placental weight. This finding is consistent with the preferential localization of the insulin receptors in the fetal endothelium of the placenta in the last trimester of pregnancy.

Abbreviations: EFSOCH, Exeter Family Study of Childhood Health • GCK, glucokinase


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2008 by the American Diabetes Association.